rational
respiratori
syncyti
viru
rsv
streptococcu
pneumonia
major
respiratori
pathogen
coinfect
rsv
pneumonia
associ
sever
often
fatal
pneumonia
molecular
basi
remain
unclear
object
determin
interact
rsv
pneumococci
enhanc
pneumococc
virul
method
use
confoc
microscopi
western
blot
identifi
receptor
involv
direct
bind
rsv
pneumococci
effect
studi
vivo
vitro
model
infect
human
ciliat
respiratori
epitheli
cell
cultur
infect
rsv
hour
challeng
pneumococci
pneumococci
collect
hour
exposur
chang
gene
express
determin
use
quantit
realtim
polymeras
chain
reaction
measur
main
result
follow
incub
rsv
purifi
g
protein
pneumococci
demonstr
signific
increas
inflammatori
respons
bacteri
adher
human
ciliat
epitheli
cultur
markedli
increas
virul
pneumonia
model
mice
associ
extens
chang
pneumococc
transcriptom
signific
upregul
express
key
pneumococc
virul
gene
includ
gene
pneumococc
toxin
pneumolysin
show
mechanist
caus
rsv
g
glycoprotein
bind
penicillin
bind
protein
conclus
direct
interact
respiratori
viru
protein
pneumococcu
result
increas
bacteri
virul
worsen
diseas
outcom
new
paradigm
respiratori
infect
streptococcu
pneumonia
also
known
pneumococcu
major
respiratori
pathogen
caus
huge
global
healthcar
burden
predominantli
young
children
elderli
global
rsv
diseas
burden
estim
million
case
death
everi
year
pneumococc
pneumonia
result
million
death
year
worldwid
approxim
half
million
children
younger
year
increas
evid
rsv
pneumococcu
interact
increas
sever
respiratori
diseas
season
increas
infect
rsv
young
children
strongli
associ
subsequ
increas
hospit
admiss
invas
pneumococc
diseas
studi
mice
also
show
signific
increas
pneumococc
sepsi
decreas
clearanc
pneumococci
lung
mice
previous
infect
rsv
increas
evid
interplay
bacteri
viral
pathogen
import
understand
molecular
mechan
involv
develop
intervent
present
new
paradigm
rsv
markedli
increas
virul
pneumococcu
directli
bind
pneumococc
cell
surfac
protein
increas
pneumococc
virul
gene
express
rsv
subgroup
strain
origin
r
channock
nation
institut
health
bethesda
md
prepar
cell
epitheli
cell
african
green
monkey
kidney
origin
multipl
infect
pfucel
day
antibioticfre
glasgow
modifi
essenti
medium
nonessenti
amino
acid
supplement
fetal
calf
serum
infect
cell
disrupt
glass
bead
centrifug
g
minut
uninfect
cell
lysat
collect
use
method
supernat
purifi
centrifug
polyethersulphon
membran
previous
describ
viru
fraction
pfuml
collect
bronchial
epitheli
basal
medium
pneumonia
strain
nctc
chosen
wellcharacter
strain
previous
shown
virul
vivo
ex
vivo
studi
ciliat
epithelia
pneumolysindefici
mutant
wildtyp
strain
propag
tryptic
soy
broth
medium
describ
previous
human
nasal
ciliat
epithelium
obtain
nine
healthi
control
subject
histori
respiratori
diseas
none
subject
take
medic
symptomat
upper
respiratori
tract
infect
preced
week
individu
gave
consent
use
cell
local
ethic
approv
obtain
univers
leicest
committe
research
ethic
respiratori
ciliat
cell
cultur
sampl
previous
describ
briefli
brush
biopsi
cell
grown
basal
epitheli
growth
media
c
basal
cell
seed
onto
collagenco
transwel
insert
corn
cultur
airliquid
interfac
use
differenti
medium
bebm
dulbecco
modifi
eagl
medium
nm
transretino
acid
cell
cultur
rins
antibioticfre
medium
rsv
multipl
infect
pfucel
ml
appli
apic
surfac
hour
c
remov
mockinfect
cell
receiv
uninfect
cell
lysat
control
infect
continu
hour
cell
incub
cfu
pneumonia
ml
bebm
hour
c
chang
ciliari
beat
frequenc
pattern
record
use
highspe
digit
video
microscopi
hour
supernat
harvest
bacteria
recov
centrifug
bacteria
resuspend
rnalat
sigma
store
c
concentr
airway
inflamm
marker
airway
surfac
liquid
measur
use
multispot
assay
meso
scale
discoveri
md
accord
manufactur
instruct
cytokin
measur
use
human
standard
plate
human
chemokin
measur
use
highband
plate
use
sector
imag
msd
md
pneumonia
cfuml
phosphatebuff
salin
pb
resuspend
ml
purifi
rsv
strain
dilut
pb
uvinactiv
rsv
dilut
pb
uv
inactiv
remov
detect
infect
determin
plaqu
assay
altern
bacteria
incub
mgml
rsv
secret
g
protein
subgroup
b
strain
express
baculovirusinsect
cell
cultur
sinobiolog
beij
china
mgml
bovin
serum
albumin
bsa
sigma
ml
bebm
minut
hour
anim
studi
c
rotat
rack
bacteria
wash
pb
bacteria
incub
bsa
pb
minut
wash
three
time
pb
subsequ
antibodi
incub
perform
pb
contain
bsa
reagent
use
immunofluoresc
studi
rabbit
antipneumococc
capsular
polysaccharid
mgml
staten
serum
institut
copenhagen
denmark
goat
antirsv
conjug
fluorescein
isothiocyan
mgml
abcam
cambridg
uk
antibodi
incub
perform
hour
follow
three
wash
pb
bound
pneumococc
polysaccharid
primari
antibodi
detect
use
alexafluor
conjug
donkey
antirabbit
antibodi
invitrogen
paisley
uk
follow
three
final
wash
pb
bacteria
cytospun
g
minut
air
dri
clean
microscop
slide
mount
coverslip
glycerol
npropylgal
pb
mount
medium
optic
section
obtain
use
nikon
confoc
microscop
imag
render
imari
softwar
bitplan
ag
geneva
switzerland
use
maximum
intens
project
filter
show
mechan
direct
interact
respiratori
syncyti
viru
pneumococci
via
specif
protein
organ
result
bind
togeth
gene
pneumococc
virul
upregul
buffer
ad
well
incub
hour
c
plate
wash
three
time
ml
anticapsular
antibodi
mgml
ad
well
hour
c
bind
antibodi
bacteria
detect
use
alkalin
phosphataseconjug
goat
antirabbit
igg
secondari
antibodi
sigma
mgml
pnitrophenyl
phosphat
sigma
dissolv
diethanolamin
ph
mgcl
absorb
read
nm
hour
c
determin
specif
bind
well
preincub
antirsv
g
antibodi
abcam
total
ml
grown
directli
frozen
stock
od
reach
bacteria
centrifug
andwash
twice
pb
pellet
resuspend
digest
buffer
unitsml
mutanolysin
sucros
mm
mgcl
mm
trishcl
ph
mlml
proteas
inhibitor
incub
static
c
hour
lysat
centrifug
rpm
minut
supernat
frozen
c
pellet
contain
protoplast
resuspend
eb
buffer
envelop
buffer
mm
trishcl
ph
frozen
c
hour
sonic
four
cycl
sonic
cool
mm
membran
cytoplasm
protein
separ
ultracentrifug
rpm
minut
use
beckman
protein
concentr
determin
use
spectrophotomet
nanodrop
nm
equal
concentr
protein
extract
boil
separ
electrophoresi
polyacrylamid
gel
constant
half
gel
stain
colloid
coomassi
protein
sequenc
half
blot
onto
polyvinyliden
fluorid
membran
hour
membran
wash
minut
trisbuff
salin
tb
incub
block
buffer
bsa
room
temperatur
hour
membran
wash
three
time
minut
incub
hour
mgml
rsv
g
protein
block
buffer
room
temperatur
rsv
viru
blot
incub
dilut
antirsv
primari
antibodi
abcam
three
wash
perform
sampl
incub
dilut
antigoat
igg
peroxidas
conjug
develop
rabbit
sigma
secondari
antibodi
final
three
wash
perform
potenti
bind
target
protein
detect
ecl
sent
identif
univers
leicest
sequenc
servic
protein
nucleic
acid
chemistri
laboratori
dna
microarray
analysi
expos
four
differ
kind
treatment
bsa
rsv
virion
purifi
prepar
rsv
fusion
f
glycoprotein
express
baculovirusinsect
cell
cultur
rsv
g
protein
three
biolog
replic
treatment
perform
medium
bebm
cell
harvest
rna
isol
hour
treatment
procedur
regard
cell
disrupt
rna
isol
rna
qualiti
test
cdna
synthesi
label
dye
hybrid
scan
perform
describ
transcriptom
data
analyz
describ
identif
differenti
express
gene
bayesian
p
valu
less
fold
chang
cutoff
appli
microarray
data
submit
gene
express
omnibu
geo
access
number
bacteri
rna
extract
use
high
pure
total
rna
isol
system
kit
roch
accord
manufactur
instruct
sampl
immedi
process
revers
transcript
use
transcriptor
first
strand
cdna
synthesi
kit
roch
accord
manufactur
instruct
quantit
realtim
polymeras
chain
reaction
qrtpcr
perform
previous
describ
use
light
cycler
dnamast
sybr
green
kit
roch
primer
gyrb
comx
nana
nanb
nox
soda
pli
previous
describ
rel
gene
express
analyz
use
method
use
refer
gene
gyrb
refer
condit
pneumococci
expos
tissu
cultur
medium
bebm
alon
analysi
five
distinct
biolog
replica
done
qpcr
reaction
complet
triplic
p
valu
less
consid
statist
signific
group
outbr
pathogenfre
femal
mice
old
strain
harlanolac
bicest
uk
anesthet
use
isofluran
inocul
intranas
ml
pneumococci
dose
previous
shown
caus
diseas
naiv
mice
surviv
postinfect
control
one
group
mice
inocul
intranas
ml
rsv
alon
pb
follow
infect
health
statu
anim
monitor
day
symptom
score
accord
scheme
morton
griffith
six
hour
postinfect
three
mice
group
kill
cervic
disloc
lung
harvest
ml
steril
pb
weigh
homogen
viabl
count
lung
homogen
blood
determin
serial
dilut
steril
pb
plate
onto
blood
agar
plate
oxoid
basingstok
uk
supplement
volvol
hors
blood
anim
work
conduct
accord
uk
nation
regul
investig
whether
pneumococc
virul
alter
interact
rsvinfect
human
ciliat
nasal
epitheli
cell
system
close
resembl
physiolog
condit
nasopharynx
natur
environ
pneumococcalrsv
interact
ciliat
respiratori
cell
cultur
infect
rsv
mockinfect
challeng
day
later
pneumonia
follow
time
cours
secondari
bacteri
infect
follow
rsv
infect
result
show
pneumonia
adher
ciliat
epithelium
greater
number
figur
increas
p
degre
ciliari
dyskinesia
figur
ciliat
cultur
pretreat
rsv
compar
mockinfect
control
cultur
exposur
pneumococci
also
shown
form
signific
clump
bacteria
associ
ciliari
tip
rsvinfect
ciliat
cell
figur
observ
control
cell
figur
highspe
videographi
show
cilia
clump
pneumococci
adher
reduct
ciliari
beat
frequenc
ciliari
dyskinesia
reduc
ciliari
beat
frequenc
known
impair
mucociliari
clearanc
airway
infect
patient
may
contribut
enhanc
symptom
diseas
coinfect
also
enhanc
inflammatori
respons
ciliat
epithelium
addit
pneumococci
rsvinfect
cell
led
signific
p
increas
apic
secret
tumor
necrosi
factora
tabl
compar
cell
infect
rsv
alon
adher
pneumococci
hour
ciliat
epitheli
cell
previous
mockinfect
infect
rsv
hour
b
mean
sem
level
ciliat
cell
dyskinet
cilia
express
percentag
total
motil
ciliat
cell
hour
data
collect
seven
independ
experi
cell
infect
rsv
mock
infect
follow
pneumococci
infect
rsv
follow
pneumococci
control
cell
treat
bovin
serum
albumin
alon
c
rel
quantif
pneumococc
adher
c
toxicityassoci
gene
express
expos
naiv
green
bar
rsvinfect
blue
bar
human
ciliat
epitheli
cell
fold
chang
gene
express
measur
quantit
realtim
polymeras
chain
reaction
calcul
use
method
intern
control
gene
gyrb
refer
condit
pneumococci
expos
naiv
respiratori
epitheli
cell
obtain
donor
data
analyz
use
parametr
pair
test
p
valu
less
statist
signific
compar
cell
expos
pneumococci
alon
coinfect
led
signific
increas
p
level
tumor
necrosi
factora
tabl
increas
particular
interest
chemokin
respons
recruit
neutrophil
airway
patient
infect
rsv
system
ninefold
higher
follow
coinfect
median
pgml
p
compar
uninfect
control
epitheli
cell
pgml
compar
threefold
increas
follow
pneumococc
infect
alon
pgml
p
fivefold
increas
follow
rsv
infect
alon
pgml
p
suggest
dual
infect
respiratori
epithelium
may
lead
increas
number
inflammatori
cell
increas
lung
cellular
inflamm
determin
whether
increas
inflammatori
respons
link
increas
pneumococc
virul
recov
bacteri
rna
cultur
analysi
specif
virul
gene
express
qrtpcr
low
quantiti
bacteri
rna
recov
restrict
number
gene
could
studi
analysi
show
five
six
gene
studi
express
higher
level
compar
pneumococci
expos
mockinfect
epithelium
figur
sixfold
mean
sem
increas
express
gene
pneumococc
toxin
pneumolysin
pli
fourfold
increas
express
gene
neuraminidas
nana
presenc
rsvinfect
ciliat
cell
express
neuraminidas
b
nanb
nicotinamid
adenin
dinucleotid
phosphat
reduc
oxidas
nox
competencestimul
peptid
comx
gene
also
higher
detect
pneumococci
expos
mockinfect
ciliat
epithelium
downregul
transcriptom
pneumonia
see
figur
confirm
interact
use
antigen
coloc
confoc
imag
show
rsv
g
protein
directli
bind
surfac
pneumococcu
indic
arrow
yellow
region
figur
western
blot
analysi
pneumonia
membran
lysat
show
rsv
g
protein
bound
singl
pneumococc
protein
molecular
weight
approxim
kd
figur
reactiv
region
polyacrylamid
gel
contain
pneumococc
protein
excis
two
separ
gel
mass
spectrometri
detect
pneumococc
penicillinbind
protein
figur
determin
bind
rsv
affect
pneumococc
gene
express
isol
bacteri
rna
pneumococci
bound
rsv
g
protein
bsa
microarray
analysi
viabl
count
follow
direct
interact
rsv
rsv
g
protein
show
pneumococc
cfu
unchang
expos
bsa
cfuml
indic
rsv
affect
pneumococc
viabil
incub
pneumococci
rsv
purifi
rsv
g
protein
affect
bacteri
viabil
growth
characterist
compar
bsatreat
control
figur
howev
pneumococci
expos
rsv
g
protein
display
signific
differ
transcriptom
compar
pneumococci
expos
bsa
figur
show
number
gene
affect
transcriptom
profil
experi
respons
rsv
g
protein
treatment
gene
group
cluster
ortholog
group
categori
base
put
function
correspond
protein
shown
figur
total
express
gene
alter
upregul
downregul
respons
rsv
g
protein
treatment
see
full
list
tabl
onlin
supplement
particular
note
signific
upregul
pneumolysin
pli
gene
toxin
encod
shown
critic
develop
invas
pneumococc
diseas
interestingli
express
gene
encod
pneumococc
receptor
rsv
also
upregul
pneumococci
follow
exposur
rsv
g
protein
see
tabl
consist
mass
spectrometri
result
test
hypothesi
bind
rsv
directli
enhanc
virul
pneumococcu
incub
pneumococci
purifi
prepar
rsv
use
pneumococci
challeng
mice
intranas
infect
subleth
dose
rsvexpos
pneumococci
result
develop
pneumococc
diseas
hour
postinfect
mice
reach
predefin
endpoint
cull
hour
figur
contrast
mice
receiv
dose
pneumococci
origin
articl
alon
expos
bsa
surviv
challeng
without
sign
diseas
figur
comparison
condit
score
mice
challeng
rsvexpos
pneumococci
show
mice
fare
significantli
wors
p
group
infect
pneumococci
alon
figur
viabl
count
bacteria
lung
mice
challeng
rsvexpos
control
pneumococci
hour
show
bacteria
replic
similar
level
p
figur
suggest
enhanc
virul
properti
increas
bacteri
replic
lung
surprisingli
rapid
develop
diseas
impli
immunemedi
respons
previou
studi
show
mice
receiv
sequenti
infect
rsv
pneumococci
significantli
greater
inflamm
high
level
accumul
neutrophil
compar
control
mice
mice
inocul
pathogen
separ
mice
infect
rsv
strain
alon
develop
sign
ill
studi
period
figur
elimin
possibl
toxic
effect
rsv
prepar
demonstr
first
time
direct
interact
rsv
pneumonia
increas
bacteri
virul
use
human
respiratori
epitheli
cell
mous
model
infect
made
major
find
bind
rsv
pneumococci
mediat
extracellular
domain
rsv
g
protein
pneumococc
protein
increas
pneumococc
virul
gene
express
lead
increas
fatal
mice
increas
bacteri
adher
infect
human
differenti
ciliat
respiratori
epithelium
unlik
previou
studi
use
monolay
human
cell
cultur
model
studi
use
fulli
differenti
ciliat
human
respiratori
epitheli
cell
system
studi
data
show
coinfect
led
increas
ciliari
dyskinesia
known
impair
mucociliari
clearanc
airway
infect
patient
may
contribut
enhanc
symptom
diseas
also
increas
apic
secret
particular
interest
chemokin
respons
recruit
neutrophil
airway
patient
infect
rsv
data
suggest
increas
cytokin
releas
epitheli
cell
ciliari
dysfunct
caus
rsv
treatment
addit
rather
synergist
respons
pneumococcu
alon
would
impli
rsv
induc
chang
pneumococcu
dosedepend
fashion
level
rsv
present
may
influenc
diseas
outcom
suggest
coinfect
respiratori
epithelium
rsv
pneumococcu
may
lead
increas
number
inflammatori
cell
increas
lung
cellular
inflamm
pneumonia
thought
initi
infect
adher
epitheli
cell
line
nasopharynx
pneumococci
adher
human
ciliat
epitheli
cell
greater
number
form
bacteri
aggreg
associ
ciliari
tip
rsvinfect
ciliat
cultur
aggreg
bacteria
appear
move
time
beat
cilia
suggest
attach
cilia
bacteri
aggreg
observ
control
cultur
increas
pneumococc
adher
could
result
increas
express
enzym
neuraminidas
bacteria
neuraminidas
major
pneumococc
virul
factor
involv
biofilm
format
adher
host
respiratori
tract
epitheli
cell
possibl
clear
host
cell
surfac
structur
bacteri
rna
recov
follow
exposur
rsvinfect
cell
show
higher
level
neuraminidas
nana
neuraminidas
b
nanb
gene
express
compar
pneumococci
expos
control
cultur
altern
increas
pneumococc
adher
could
caus
presenc
rsv
g
protein
infect
host
cell
previou
studi
suggest
rsv
act
direct
coupl
particl
bacteria
epitheli
cell
previou
work
show
rsv
g
protein
express
ciliari
tip
consist
rsv
g
protein
act
bacteri
receptor
increas
bacteri
adher
site
second
form
rsv
g
protein
secret
infect
cell
therefor
potenti
directli
alter
virul
pneumococci
present
nasopharynx
rsv
g
protein
directli
bind
pneumococc
bind
rsv
g
protein
led
signific
chang
pneumococc
transcriptom
absenc
infect
cell
includ
upregul
gene
encod
ciar
ciah
togeth
regul
virul
compet
pneumonia
addit
gene
pneumolysin
pli
also
upregul
follow
exposur
rsv
g
protein
consist
previou
qrtpcr
result
show
bacteria
recov
rsvinfect
ciliat
cell
cultur
display
signific
upregul
pli
major
new
find
toxin
encod
shown
critic
develop
invas
pneumococc
diseas
blockad
pneumolysin
repres
new
target
antipneumococc
therapi
mutant
defici
pneumolysin
lethal
mice
pretreat
mutant
rsv
result
increas
virul
see
figur
surviv
curv
mice
challeng
intranas
cfu
streptococcu
pneumonia
previous
expos
rsv
dark
blue
expos
rsv
alon
light
blue
expos
bovin
serum
albumin
bsa
alon
rsv
bsa
alon
data
overlap
complet
pale
blue
b
condit
score
mice
hour
challeng
either
wildtyp
pneumonia
previous
expos
rsv
expos
rsv
alon
expos
pneumococci
alon
hour
statist
signific
chang
p
c
viabl
count
pneumonia
recov
lung
mice
hour
challeng
cfu
pneumonia
previous
expos
either
bsa
control
pneumococci
rsv
hour
nd
signific
differ
p
n
indic
rsvinduc
increas
pneumococc
virul
requir
pneumolysin
express
shown
prior
infect
rsv
increas
suscept
mice
subsequ
bacteri
pneumonia
decreas
pneumococc
clearanc
studi
simultan
treatment
rsv
pneumococcu
led
signific
diseas
rapid
death
histopatholog
examin
mice
lung
follow
pneumococc
challeng
figur
show
lung
patholog
absent
group
mice
except
mice
challeng
pneumococci
expos
rsv
one
mous
group
five
extens
immun
cell
recruit
indic
immun
mediat
process
develop
mortal
consid
signific
interact
rsv
g
protein
pneumococc
virul
extens
sequenc
variat
g
protein
differ
rsv
isol
two
question
immedi
aris
enhanc
pneumococc
virul
seen
clinic
rsv
isol
variat
respons
bacteria
g
protein
differ
clinic
strain
rsv
whole
viru
experi
report
use
subgroup
viru
wherea
purifi
subgroup
b
g
protein
use
interact
assay
gener
enhanc
diseas
suggest
g
protein
subgroup
capac
enhanc
pneumococc
diseas
howev
investig
potenti
inher
variat
interact
permit
us
uncov
key
molecular
motif
identifi
highrisk
serotyp
pathotyp
current
investig
conclus
data
show
first
time
direct
interact
rsv
pneumonia
induc
express
pathogen
determin
lead
fatal
infect
mice
increas
pathogenesi
human
respiratori
system
data
also
show
result
diseas
process
requir
function
pneumolysin
toxin
studi
provid
novel
insight
molecular
mechan
underli
secondari
pneumococc
diseas
wider
implic
interplay
respiratori
pathogen
n
